SARTORIUS STEDIM BIOTECH (56S1.DE) Earnings History & Surprises
FRA:56S1 • FR0013154002
169.05 EUR
0 (0%)
Last: Mar 9, 2026, 07:00 PM
Past quarterly earnings results for SARTORIUS STEDIM BIOTECH (56S1.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateN/A
PeriodQ1 / 2026
EPS Estimate€1.27
Revenue Estimate765.39M
Last Reported
Release DateFeb 3, 2026
PeriodQ4 / 2025
EPS Reported€1.12
EPS Surprise -12.72%
Revenue Surprise -4.17%
Beat Rate
44%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (EUR)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.12 | 1.28 | -12.72% | 8.74% | 772.2M | 805.83M | -4.17% | 2.78% |
| Q3 2025 | 0.94 | 0.96 | -2.24% | 23.68% | 705.7M | 734.65M | -3.94% | 7.67% |
| Q2 2025 | 1.18 | 1.07 | 10.22% | 38.82% | 745M | 742.74M | 0.30% | 5.46% |
| Q1 2025 | 1.16 | 0.95 | 22.18% | 34.88% | 744.6M | 719.3M | 3.52% | 11.65% |
| Q4 2024 | 1.03 | 0.96 | 7.63% | 43.06% | 751.3M | 730.06M | 2.91% | 6.30% |
| Q3 2024 | 0.76 | 0.81 | -5.62% | -10.59% | 655.4M | 690.73M | -5.11% | -1.72% |
| Q2 2024 | 0.85 | 1.07 | -20.27% | -28.57% | 706.4M | 696.1M | 1.48% | 4.54% |
| Q1 2024 | 0.86 | 0.95 | -9.42% | -39.86% | 666.9M | 726.14M | -8.16% | -8.15% |
| Q4 2023 | 0.72 | 0.85 | -15.13% | -65.05% | 706.8M | 659.45M | 7.18% | -20.58% |
| Q3 2023 | 0.85 | 2.81 | -69.78% | -61.01% | 666.9M | 723.67M | -7.84% | -24.08% |
| Q2 2023 | 1.19 | 2.15 | -44.76% | -45.66% | 675.7M | 709.53M | -4.77% | -21.59% |
| Q1 2023 | 1.43 | 1.44 | -0.76% | -35.29% | 726.1M | 733.36M | -0.99% | -15.81% |
| Q4 2022 | 2.06 | 2.17 | -5.05% | 6.19% | 890M | 917.58M | -3.01% | 14.37% |
| Q3 2022 | 2.18 | 3.05 | -28.54% | 7.39% | 878.4M | 906.82M | -3.13% | -58.35% |
| Q2 2022 | 2.19 | 3.27 | -33.08% | 18.38% | 861.8M | 883.44M | -2.45% | 23.70% |
| Q1 2022 | 2.21 | 2.79 | -20.84% | 34.76% | 862.5M | 787.82M | 9.48% | 31.64% |
| Q4 2021 | 1.94 | 1.83 | 5.83% | 70.18% | 778.177M | 755.82M | 2.96% | 46.64% |
| Q3 2021 | 2.03 | 1.85 | 9.83% | 69.17% | 2.109B | 703.67M | 199.69% | 313.17% |
| Q2 2021 | 1.85 | 1.57 | 18.17% | 94.74% | 696.7M | 670.5M | 3.91% | 55.86% |
| Q1 2021 | 1.64 | 1.46 | 11.98% | 88.51% | 655.2M | 584.79M | 12.04% | 55.22% |
| Q4 2020 | 1.14 | 1.09 | 4.70% | - | 530.681M | 490.04M | 8.29% | - |
| Q3 2020 | 1.20 | 0.95 | 25.73% | - | 510.4M | 456.85M | 11.72% | - |
| Q2 2020 | 0.95 | 0.91 | 4.28% | - | 447M | 454.6M | -1.67% | - |
| Q1 2020 | 0.87 | 0.77 | 13.71% | - | 422.1M | 403.42M | 4.63% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
4.36%
Max EPS beat (4)
22.18%
Min EPS beat (4)
-12.72%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-1.07%
Max Revenue beat (4)
3.52%
Min Revenue beat (4)
-4.17%
Analysis
In the last 4 quarters, 56S1.DE has beaten EPS estimates in 2 out of 4 releases
56S1.DE has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, 56S1.DE has beaten the EPS estimates by 4.4% on average.
In the last 4 quarters, 56S1.DE reported -1.1% below the revenue estimates on average.
SARTORIUS STEDIM BIOTECH / 56S1.DE Earnings FAQ
When did SARTORIUS STEDIM BIOTECH (56S1.DE) report earnings last quarter?
SARTORIUS STEDIM BIOTECH (56S1.DE) last reported earnings on 2/3/2026.
Can you provide information on whether SARTORIUS STEDIM BIOTECH beat earnings estimates in the last quarter?
SARTORIUS STEDIM BIOTECH (56S1.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does SARTORIUS STEDIM BIOTECH (56S1.DE) beat earnings estimates?
In the last 4 quarters, SARTORIUS STEDIM BIOTECH (56S1.DE) has beaten EPS estimates in 2 out of 4 releases.